Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
Targeted Internal Radiation Therapy in Advanced HCC Patients.
Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
† Study has passed its completion date and status has not been verified in more than two years.